Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: A critical discussion and two case reports

Head and Face Medicine

Volumn 7, Issue 1, 2011, Pages

  Conte Neto, Nicolau ^a   Bastos, Alliny S ^a   Spolidorio, Luis C ^a   Marcantonio, Rosemary A C ^a   Marcantonio Jr, Elcio ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

AGED; ARTICLE; BONE NECROSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; JAW DISEASE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RHEUMATOID ARTHRITIS;

ADMINISTRATION, ORAL; AGED; ALENDRONATE; ARTHRITIS, RHEUMATOID; BONE DENSITY CONSERVATION AGENTS; DIAGNOSIS, DIFFERENTIAL; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; MIDDLE AGED; OSTEONECROSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79955156593     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/1746-160X-7-7     Document Type: Article

References (31)

1. Park W, Kim NK, Kim MY, Rhee YM, Kim HJ. Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases. Osteoporos Int 2010, 21:527-33. 10.1007/s00198-009-0973-3, 19484166.
2. Malden N, Beltes C, Lopes V. Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm. Br Dent J 2009, 206:93-8. 10.1038/sj.bdj.2009.5, 19165270.
3. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005, 4:130-6. 10.1016/j.autrev.2004.09.002, 15823498.
4. Santos C, Alegre C. Osteonecrosis maxilar, bifosfonatos y artritis reumatoide. Med Clin 2008, 130:37.
5. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 2009, 67:61-70.
6. Patschan D, Loddenkemper K, Buttgereit F. Molecular mechanisms of glucocorticoid induced osteoporosis. Bone 2001, 29:498-505. 10.1016/S8756-3282(01)00610-X, 11728918.
7. Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med 2010, 362:1005-13. 10.1056/NEJMoa0903036, 2845924, 20237346.
8. Jain A, Witbreuk M, Ball C, Nanchahal J. Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery. J Hand Surg Am 2002, 27:449-55. 10.1053/jhsu.2002.32958, 12015719.
9. Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int 2007, 18:1363-70. 10.1007/s00198-007-0384-2, 17598065.
10. Marx RE, Cillo JE, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007, 65:2397-410. 10.1016/j.joms.2007.08.003, 18022461.
11. Barros SY. Is your knowledge up-to-date? Bisphosphonate-related osteonecrosis of the jaw. Int J Dent Hyg 2008, 6:376-7. 10.1111/j.1601-5037.2008.00342.x, 19138190.
12. Junquera L, Gallego L, Cuesta P, Pelaz A, de Vicente JC. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases. Am J Otolaryngol 2009, 30:390-5. 10.1016/j.amjoto.2008.07.014, 19880027.
13. Elad S, Gomori MJ, Ben-Ami N, Friedlander-Barenboim S, Regev E, et al. Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation. Clin Oral Investig 2010, 14:43-50. 10.1007/s00784-009-0311-3, 19603201.
14. Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 2010, 68:243-53. 10.1016/j.joms.2009.03.050, 19772941.
15. Zigic TM, Marcous C, Hungerford DS. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosis. Am J Med 1985, 79:596-604. 10.1016/0002-9343(85)90057-9, 4061472.
16. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bone changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol 2009, 45:164-72. 10.1016/j.oraloncology.2008.04.013, 18715819.
17. Yip RML. Bisphosphonates and Osteonecrosis of the Jaw. Hong Kong Bull Rheum Dis 2008, 8:19-25.
18. Breuil V, Euller-Ziegler L. Bisphosphonate therapy in rheumatoid arthritis. Joint Bone Spine 2006, 73:349-54. 10.1016/j.jbspin.2005.10.019, 16616575.
19. Joffe I, Epstein S. Osteoporosis associated with rheumatoid arthritis: Pathogenesis and management. Seminars in Arthritis and Rheumatism 1991, 20:256-272. 10.1016/0049-0172(91)90021-Q, 2042057.
20. Bartold PM, Marshall RI, Haynes DR. Periodontitis and rheumatoid arthritis: a review. J Periodontol 2005, 76:2066-74. 10.1902/jop.2005.76.11-S.2066, 16277578.
21. Snyderman R, McCarty GA. Analogous mechanisms of tissue destruction in rheumatoid arthritis and periodontal disease. Host-Parasite Interaction in Periodontal Disease 1982, 1:354-362. Washington, DC: American Society for Microbiology, Genco RJ, Mergenhagen SE, 1.
22. Lesclous P, Abi Najm S, Carrel JP, Baroukh B, Lombardi T, et al. Bisphosphonate associated osteonecrosis of the jaw: a key role of inflammation?. Bone 2009, 45:843-52. 10.1016/j.bone.2009.07.011, 19631301.
23. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 2007, 29:1548-58. 10.1016/j.clinthera.2007.08.008, 17919538.
24. Sedghizadeh PP, Stanley K, Caligiuri M, Hofkes S, Lowry B, Shuler CF. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry. J Am Dent Assoc 2009, 140:61-6.
25. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005, 63:1567-75. 10.1016/j.joms.2005.07.010, 16243172.
26. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons. J Oral Maxillofac Surg 2009, 67:2-12.
27. Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease?. J Clin Periodontol 2000, 27:267-72. 10.1034/j.1600-051x.2000.027004267.x, 10783841.
28. Modi DK, Chopra VS, Bhau U. Rheumatoid arthritis and periodontitis: biological links and the emergence of dual purpose therapies. Indian J Dent Res 2009, 20:86-90. 10.4103/0970-9290.49070, 19336867.
29. Favia G, Pilolli GP, Maiorano E. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients. J Rheumatol 2009, 36:2780-7. 10.3899/jrheum.090455, 19884275.
30. Malden NJ, Pai AY. Oral bisphosphonate associated osteonecrosis of the jaws: three case reports. Br Dent J 2007, 203:93-7. 10.1038/bdj.2007.636, 17660780.
31. Kunchur R, Need A, Hughes T, Goss A. Clinical investigation of C-terminal cross linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 2009, 67:1167-73. 10.1016/j.joms.2009.02.004, 19446200.